Abstract
Childhood obesity and its related comorbidities are increasingly recognised in children, predisposing them to early cardiovascular disease and metabolic syndrome. The objective of the study was to investigate markers of metabolism, inflammation and haemostasis in a group of Italian obese children and adolescents. Fifty-nine obese and 40 non-obese subjects were recruited. Fasting glucose and insulin, total cholesterol, HDL and LDL cholesterol, triglycerides, high-sensitivity C-reactive protein (hsCRP), tumour necrosis factor alpha (TNF-α), and adiponectin were measured. Hypercoagulability was assessed by measuring the circulating levels of thrombin-antithrombin complex (TAT), D-dimer, fibrinogen, plasminogen activator inhibitor 1 (PAI-1) and von Willebrand Factor (vWF). A significant degree of insulin resistance was present in obese subjects compared with controls (p < 0.0001). The obese showed higher levels of total cholesterol, LDL cholesterol and triglycerides, and lower levels of HDL cholesterol than controls (p < 0.0001). Circulating levels of hsCRP and TNF-α were significantly higher in obese than in controls while serum adiponectin levels were significantly lower in obese than non-obese subjects (p < 0.001; p = 0.031; p < 0.0001, respectively). vWF, TAT, D-dimer, fibrinogen and PAI-1 levels were significant higher in obese subjects compared with control group (p = 0.02; p < 0.0001; p = 0.0037; p < 0.0001; p = 0.017, respectively). In conclusion, our results suggest that childhood obesity per se is associated with a proinflammatory and prothrombotic state.
Similar content being viewed by others
References
Am C, Caprio S (2008) Obesity in children and adolescents. J Clin Endocrinol Metab 93:S31–S36
Atabek ME (2008) Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents. J Pediatr Endocrinol Metab 21:603–604
Caballero AE, Bousquet-Santos K, Robles-Osorio L et al (2008) Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diab Care 31:576–582
Cacciari E, Milani S, Balsamo A et al (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Investig 29:581–593
Cole TJ, Bellizzi MC, Flegal KM et al (2000) Establishing a standard definition for child overweight and obesity worldwide: International survey. Brit Med J 7244:1240–1243
Cook JM, Semple RK (2010) Hypoadiponectinemia—cause or consequence of human “insulin resistance”? J Clin Endocrinol Metab 95:1544–1554
Daniels SR (2006) The consequences of childhood overweight and obesity. Future Child 16:47–67
Ferguson MA, Gutin B, Owens S et al (1999) Effect of physical training and its cessation on the hemostatic system of obese children. Am J Clin Nutr 69:1130–1134
Gallistl S, Sudi KM, Borkenstein M et al (2000) Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis 11:755–760
Gilardini L, McTernan PG, Girola A et al (2006) Adiponectin is a candidate marker of metabolic sindrome in obese children and adolescents. Atherosclerosis 189:401–407
Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes 27:S53–S55
Iñiguez G, Torrealba IM, Avila A et al (2008) Adiponectin serum levels and their relationships to androgen concentrations and ovarian volume during puberty in girls with type 1 diabetes mellitus. Horm Res 70:112–117
Kato H, Kahiwagi H, Shiraga M et al (2006) Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 26:224–230
Klein S, Burke LE, Bray GA, American Heart Association Council on Nutrition, Physical Activity, and Metabolism et al (2004) Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 110:2952–2967
Martos R, Valle M, Morales RM et al (2009) Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss. Metabolism 58:1153–1160
Masuccio FG, Lattanzio FM, Matera S et al (2009) Insulin sensitivity in prepubertal Caucasian normal weight children. J Clin Endocrinol Metab 22:695–702
Mauras N, Delgiorno C, Kollman C et al (2010) Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 95:1060–1068
Meigs JB, O’donnell CJ, Tofler GH et al (2006) Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55:530–537
Ritchie SA, Connell JM (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17:319–26
Romano M, Guagnano MT, Pacini G (2003) Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88:5321–5326
Tan KC, Xu A, Chow WS et al (2004) Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89:765–769
Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170–179
Tchernova J, Whincup P, Lowe GD et al (2009) Plasma leptin: associations with metabolic, inflammatory and hemostatic risk factors for cardiovascular disease. Atherosclerosis 191:418–426
Valle Jiménez M, Estepa RM, Camacho RM et al (2007) Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 156:497–502
Valle M, Martos R, Gascon F et al (2005) Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diab Metab 31:55–62
Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374
Williams CL, Hayman LL, Daniels SR et al (2002) Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106:143–160
World Health Organization Department of Non communicable Disease Surveillance (1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Geneva, World Health Organization
Wozniak SE, Gee LL, Wachtel MS et al (2009) Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54:1847–1856
Yamamoto K, Takeshita K, Tetsuhito K et al (2005) Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in elderly. Cardiovasc Res 66:276–285
Yasar S, Nurgun K, Ayfer A et al (2008) Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 167:1183–1189
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors do not have any financial relationship with the organization that sponsored the research.
Rights and permissions
About this article
Cite this article
Giordano, P., Del Vecchio, G.C., Cecinati, V. et al. Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr 170, 845–850 (2011). https://doi.org/10.1007/s00431-010-1356-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-010-1356-7